Borrelien IgG ELISA/人包柔氏螺旋体IgG抗体ELISA检测试剂盒

原厂品牌:BIOMEDICA

规格选择
货号规格目录价货期
BI-2103212 x 8 tests¥4,6903~4周

产品详情

Lyme borreliosis is a bacterial infection caused by the spirochete Borrelia Burgdorferi, Borrelia Afzelii and Borrelia Garinii and is the most vector-transmitted human disease in Europe. The spirochetal bacteria were first described and isolated in 1981 by Willi Burgdorfer in the tick Ixodes dammini in Montana (USA). The infection with Borrelia is characterized by a variety of clinical symptoms and can be divided into 3 stages: Stage 1, early dermatitis, appearing days or weeks after the infection. Clinical: erythema migrans. Stage 2, early disseminated infection, appears weeks to months after infection. Clinical: lymphocytic meningoradiculitis (Bannwarth's syndrome), neuroborreliosis. Stage 3, late disseminated infection, occurring up to years after infection. Clinical: chronic progressive encephalomyelitis, acrodermatitis chronica atrophicans (ACA), chronic arthritis. Antibiotic therapy is indicated in all stages of the disease. It shortens disease duration significantly, when instituted in stage 1. Diagnosis of the bacterial infection relies on the detection of specific IgG antibodies against Borrelia. To ensure diagnostic specificity, the Borrelia IgG ELISA microwell strips are coated with the following Borellia-specific recombinant antigens: p18: B. afzelii (pKo) p21 = OspC (outer surface protein C): B. burgdorferi s.s. (B31), B. garinii (20047) p100: B. afzelii (pKo) VlsE: fusion protein of different genospecies Many features of later infection are not specific to Lyme Borreliosis and occur in other conditions. The diagnosis of Lyme Borreliosis should be made only after careful evaluation of the patient´s clinical history, physical findings, laboratory evidence and exposure risk evaluation.

The Borrelia IgG immunoassay is a 2 hour, 96-well indirect ELISA for the qualitative or quantitative determination of Borrelia IgG antibodies in human serum, plasma and cerebrospinal fluid (CSF) samples. The Borrelia assay employs human serum-based standards to ensure the measurement of biologically reliable data.

The Borrelia test kit uses a recombinant antigen mix to improve the diagnostic specificity:

- p18: B. afzelii (pKo)

- p21 = OspC (outer surface protein C): B. burgdorferi s.s (B31), B. garinii (20047)

- p100: B. afzelii (pKo)

- VlsE: fusion proteins of different Borrelia genospecies

共 0 条

暂无评价